No menu items!
Saturday, June 7, 2025

M/s Zydus Cadila

DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials

The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by...
- Advertisement -spot_img

Latest News

Venture Capital Bets on AI for Smarter Investing

Venture capital firms in India are increasingly embracing artificial intelligence (AI) and automation to enhance efficiency in sourcing and...
- Advertisement -spot_img